首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   8941篇
  免费   917篇
  国内免费   913篇
  2024年   6篇
  2023年   83篇
  2022年   122篇
  2021年   335篇
  2020年   294篇
  2019年   334篇
  2018年   353篇
  2017年   290篇
  2016年   397篇
  2015年   591篇
  2014年   706篇
  2013年   706篇
  2012年   852篇
  2011年   853篇
  2010年   520篇
  2009年   453篇
  2008年   592篇
  2007年   528篇
  2006年   458篇
  2005年   420篇
  2004年   394篇
  2003年   305篇
  2002年   293篇
  2001年   177篇
  2000年   138篇
  1999年   113篇
  1998年   86篇
  1997年   64篇
  1996年   42篇
  1995年   39篇
  1994年   33篇
  1993年   19篇
  1992年   24篇
  1991年   23篇
  1990年   17篇
  1989年   17篇
  1988年   17篇
  1987年   10篇
  1986年   7篇
  1985年   6篇
  1984年   6篇
  1983年   8篇
  1982年   5篇
  1981年   8篇
  1980年   2篇
  1979年   6篇
  1978年   7篇
  1966年   1篇
  1965年   5篇
  1950年   1篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
52.
木聚糖酶分子结构与重要酶学性质关系的研究进展   总被引:10,自引:0,他引:10  
木聚糖是一种多聚五碳糖 ,是植物细胞中主要的半纤维素成分。木聚糖酶是可将木聚糖降解成低聚木糖和木糖的水解酶 ,它在饲料、造纸、食品、能源工业和环境科学上有着广阔的应用前景。随着分子生物学、结构生物学的发展及蛋白质工程的应用 ,对木聚糖酶结构和功能的研究不断深入。这里重点阐述与酶的活性、热稳定性、作用pH、等电点、底物亲和性及催化效率等重要性质相关的分子结构研究进展 ,讨论了其进一步的研究发展方向。研究木聚糖酶结构与功能的关系 ,对进一步加深木聚糖酶作用机制的了解、指导木聚糖酶的分子改良有重要意义。  相似文献   
53.
为研究A、C、Y、W 135群流脑多糖疫苗,针对W 135群脑膜炎球菌的生长特性,采用国产50L发酵罐,针对流脑半综合液体培养基中葡萄糖浓度;培养温度、菌种接种浓度、pH、通氧量及搅拌速度等因素对W 135群脑膜炎球菌生长的影响,选择最适的培养条件。结果表明,选择半综合培养基中补加1%的葡萄糖培养效果良好,菌种接种浓度直接影响多糖复合物产量;最适pH值6.5~7.5的范围可维持W 135群链球菌快速生长;温度控制在36.5±0.2℃可得到较高的培养产物;培养过程中加大通气量及搅拌速度对培养结果有明显改善。确立了W 135群脑膜炎球菌的最适培养条件,在确定培养条件后连续进行3批500L罐放大中试培养,达到规模化生产要求。  相似文献   
54.
植物内生固氮菌研究进展   总被引:2,自引:0,他引:2  
综述了植物内生固氮菌生物多样性、生物学特性 ,生理特性 ,与寄主植物的相互作用及应用前景等方面的研究进展。  相似文献   
55.
黄化油菜突变体Cr3529子叶类囊体膜光谱性质研究   总被引:6,自引:3,他引:3  
以发育10d的黄化油菜突变体为材料,分析了突变体油菜子叶类囊体膜的色素含量、室温吸收光谱、叶绿素荧光发射和激发光谱以及蛋白内源荧光光谱的变化。数据显示:与野生型相比,突变体油菜子叶类囊体膜的光合色素Chl α和Chl b含量均减少.但Chl α/b比值升高;突变体油菜子叶类囊体膜叶绿素捕光能力和受激发能力均下降,且较依赖于Chl α捕光并将光能激发传递给PSⅡ反应中心;突变体油菜子叶类囊体膜的蛋白内源荧光也明显异于野生型。进一步表明突变体油菜子叶类囊体膜蛋白组成发生了改变。  相似文献   
56.
To understand the prevalence and evolution of drug resistant HIV strains in Henan China after the implementation of free antiretroviral therapy for AIDS patients. 45 drug naive AIDS patients, 118 AIDS patients who received three months antiretroviral therapy and 124 AIDS patients who received six months antiretroviral treatment were recruited in the southern part of Henan province. Information on general condition, antiretroviral medicines, adherence and clinical syndromes were collected by face to face interview. Meanwhile, 14ml EDTA anticoagulant blood was drawn. CD4/CD8 T cell count, viral load and genotypic drug resistance were tested. The rates of clinical improvement were 55.1% and 50.8% respectively three months and six months after antiretroviral therapy. The mean CD4 cell count after antiretroviral therapy was significantly higher than in drug naive patients. The prevalence rate of drug resistant HIV strains were 13.9%, 45.4% and 62.7% in drug naive patients, three month treatment patients and six month treatment patients, respectively.The number of resistance mutation codons and the frequency of mutations increased significantly with continued antiretroviral therapy. The mutation sites were primarily at the 103, 106 and 215 codons in the three-month treatment group and they increased to 15 codon mutations in the six-month treatment group. From this result, the evolution of drug resistant strains was inferred to begin with the high level NNRTI resistant strain, and then develop low level resistant strains to NRTIs. The HIV strains with high level resistance to NVP and low level resistance to AZT and DDI were highly prevalent because of the AZT DDI NVP combination therapy. These HIV strains were also cross resistant to DLV, EFV, DDC and D4T. Poor adherence to therapy was believed to be the main reason for the emergence and prevalence of drug resistant HIV strains. The prevalence of drug resistant HIV strains was increased with the continuation of antiretroviral therapy in the southern part of Henan province. Measures, that could promote high level adherence,provide new drugs and change ART regimens in failing patients, should be implemented as soon as possible.  相似文献   
57.
Iminodiacetate–DNA conjugates and acridine–DNA conjugates were synthesized and combined for site-selective RNA hydrolysis by Lu(III). When these conjugates form a ternary complex with complementary RNA, the Lu(III)–iminodiacetate complex is placed near the target phosphodiester linkage of RNA which is in front of the acridine and is activated by noncovalent interactions. The site-selective hydrolysis by these combinations is several times as fast as that achieved by combining unmodified DNA (without iminodiacetate) and the acridine–DNA conjugate.Electronic Supplementary Material Supplementary material is available for this article at .  相似文献   
58.
In this study, the reactions of N-acetyl-L-methionine (AcMet) with [{trans-PtCl(NH3)2}2-μ-H2N(CH2)6NH2](NO3)2 (BBR3005: 1,1/t,t 1) and its cis analog [{cis-PtCl(NH3)2}2-μ-{H2N(CH2)6NH2}]Cl2 (1,1/c,c 2) were analyzed to determine the rate and reaction profile of chloride substitution by methionine sulfur. The reactions were studied in PBS buffer at 37°C by a combination of multinuclear (195Pt, {1H-15N} HSQC) magnetic resonance (NMR) spectroscopy and electrospray ionization time of flight mass spectrometry (ESITOFMS). The diamine linker of the 1,1/t,t trans complex was released as a result of the trans influence of the coordinated sulfur atom, producing trans-[PtCl(AcMet)(NH3)2]+ (III) and trans-[Pt(AcMet)2(NH3)2]2+ (IV). In contrast the cis geometry of the dinuclear compound maintained the diamine bridge intact and a number of novel dinuclear platinum compounds obtained by stepwise substitution of sulfur on both platinum centers were identified. These include (charges omitted for clarity): [{cis-PtCl(NH3)2}-μ-NH2(CH2)6NH2-{cis-Pt(AcMet)(NH3)2}] (V); [{cis-Pt(AcMet)(NH3)2}2-μ-NH2(CH2)6NH2] (VI); [{cis-PtCl(NH3)2}-μ-NH2(CH2)6NH2-{PtCl(AcMet)NH3] (VII); [{PtCl(AcMet)(NH3)}2-μ-NH2(CH2)6NH2] (VIII); [{trans-Pt(AcMet)2(NH3)}-μ-NH2(CH2)6NH2-{PtCl(AcMet)(NH3)] (IX) and the fully substituted [{trans-Pt(AcMet)2(NH3)}2-μ-{NH2(CH2)6NH2] (X). For both compounds the reactions with methionine were slower than those with glutathione (Inorg Chem 2003, 42:5498–5506). Further, the 1,1/c,c geometry resulted in slower reaction than the trans isomer, because of steric hindrance of the bridge, as observed previously in reactions with DNA and model nucleotides.  相似文献   
59.
测定并比较分析了真蝽属(Pentatoma)5种昆虫:褐真蝽P.semiannulata、斜纹真蝽P.illuminata、红足真蝽P.rufipes、H本真蝽P.japonica和金绿真蝽P.metallifera以及益蝽亚科2种外群种类(并蝽Pinthaeus humeralis和蠋蝽Arma custos)mtDNA—COII基因部分序列,依据分子数据建立了该5种昆虫的系统发育关系。结果显示,5种真蝽COII基因A T平均含量(73%)高丁弹尾目、缨尾目和直翅目昆虫,低于双翅目、鳞翅目及膜翅目昆虫,而与缨翅目的蓟马和半翅目的突角长蝽Oncopeltus fasciatus非常接近。系统发育结果显示,红足真蝽与日本真蝽亲缘关系最近,形成一个姊妹群,斜纹真蝽与金绿真蝽亲缘关系较近,也形成一个姊妹群,褐真蝽为较早分化的种类。  相似文献   
60.
Compared with high infection areas of the world, the total HIV infection rate in China is relatively low. Nonetheless,because of China‘s vast territory and large population, the potential infection risk must be taken seriously. In the next few years, needle sharing among injection drug users will remain the most common route of transmission for the HIV/AIDS epidemic in China. Unprotected sex is gradually becoming a major route of transmission. China began to implement HAART in 1999 according to international standards. Prior to 2003, there were only about 150 HIV/AIDS patients were treated with HAART in some clinical trials and about 100 HIV/AIDS patients were treated by private sources.Results of those treatments are the scientific basis for development of the therapeutic strategies in China. In March of 2003, the Chinese government initiated China CARES program. In November of 2003, the Chinese Ministry of Health announced a national policy of free ARV treatment to all HIV Chinese citizens who were in poverty and required ARV therapy. There are total of 19,456 HIV/AIDS patients received free ARV drugs to date in 159 regions and 441 towns.Current challenges are how to follow-up and evaluate those patients in the clinical settings. The longer the therapy is postponed, the more side effects and the higher probability of drug resistance are going to occur. It remains unclear,therefore, when HAART regimen should be started in the HIV/AIDS population in China.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号